Method of treating metabolic bone diseases with an IL-1 receptor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 10, 1998
Grant Date -
N/A
app pub date -
Jun 7, 1995
filing date -
Jun 17, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method of treating metabolic bone diseases comprising using a pharmaceutical composition which comprises as an active ingredient IL-1 receptor, a soluble fragment consisting of an extracellular domain of IL-1R or a fragment thereof derived from mammals. The composition has a bone resorption inhibiting activity and is useful for the therapy and prophylaxis of metabolic bone diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully